Business Context and Reporting Period
Company: McKesson Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: December 20, 2016
Event Date: December 21, 2016
Context: The filing reports the conclusion of the regulatory waiting period for the formation of a healthcare information technology company through a contribution and sale agreement with Change Healthcare Holdings, Inc.
Key Financial Metrics
This filing is a current report regarding a corporate event and does not contain financial statements. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
- Regulatory Clearance: The Department of Justice (DOJ) closed its review and terminated the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
- Transaction Status: This clearance relates to the contribution and sale agreement dated June 28, 2016, between McKesson Corporation and Change Healthcare to form a healthcare information technology company.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the successful termination of the antitrust waiting period, allowing the transaction to proceed. No specific financial guidance or outlook is provided in this document.
Risks and Contingencies: The primary contingency addressed was the DOJ review, which has now been resolved. No other unusual items or risks are detailed in this specific filing.
Investor Verification Checklist
- Verify the terms of the contribution and sale agreement dated June 28, 2016, to understand the structure of the new healthcare IT entity.
- Review the attached press release (Exhibit 99.1) for details on the operational impact of the Change Healthcare transaction.
- Confirm if subsequent filings (e.g., 10-K or 10-Q) reflect the financial impact of this transaction in the relevant reporting periods.